Vaxess Technologies

Constant Therapeutics LLC is a private biopharmaceutical company based in Cambridge, specializing in the development of peptide and small molecule drugs. The company is currently focused on advancing Mas receptor agonists, including their lead drug candidate, TXA127, for the treatment of COVID-19, CNS, and rare disorders. TXA127, a pharmaceutical formulation of the natural human peptide angiotensin-1-7 (Ang-1-7), represents the forefront of Constant Therapeutics' innovative approach to addressing critical medical needs through cutting-edge drug development. With a commitment to clinical excellence, the company aims to make significant advancements in the field of biopharmaceuticals. Generated from their website's infomation

Estern Medical CRO is a full Contract Research Organization based in U.S. North America and Latin America, specializing in providing services to Pharmaceutical, Biotechnology, and Medical Device companies in the Lifescience sector. With a focus on delivering comprehensive research solutions, Estern Medical CRO supports clients in the development and execution of clinical trials and regulatory submissions to advance healthcare innovations. Generated from their website's infomation

Ra Pharmaceuticals Inc, based in Cambridge, MA, is a global biopharmaceutical leader dedicated to creating valuable solutions that improve the lives of individuals living with neurological and autoimmune conditions. The company emphasizes innovation as a key driver of progress in healthcare, striving to deliver effective treatments for severe diseases. In addition to its commitment to advancing medical science, Ra Pharmaceuticals is focused on sustainability and positively impacting society while supporting communities and protecting the planet for future generations. The company also invests in pioneering technologies through UCB Ventures, aiming to transform the lives of patients worldwide. Generated from the website